- Home
- XBP vs DTIL Comparison
XBP vs DTIL Comparison
Compare XBP & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XBP | DTIL |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6M | 97.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | XBP | DTIL |
|---|---|---|
| Price | $8.33 | $4.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 29.5K | ★ 247.9K |
| Earning Date | 11-14-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,823,000.00 | $698,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.11 | $3.75 |
| 52 Week High | $25.60 | $8.82 |
Technical Indicators
Market Signals| Indicator | XBP | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 70.67 | 48.01 |
| Support Level | $7.22 | $3.90 |
| Resistance Level | $8.40 | $4.21 |
| Average True Range (ATR) | 0.59 | 0.27 |
| MACD | -0.18 | 0.05 |
| Stochastic Oscillator | 81.87 | 60.54 |
Price Performance
Historical ComparisonAbout XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.